Boston University (BU) granted rights related to a method for creating induced pluripotent stem (iPS) cells to Millipore. The cells are derived from mouse fibroblasts by using a single virus vector instead of multiple viruses in the reprogramming process, according to BU.
The vector has been licensed to Millipore for nonhuman research reagent use and is expected to be made commercially available later this year.